Femtech Market – By Type, By Application, By End Use – Global Forecast, 2024 – 2032

Femtech Market Size

The global femtech market size was valued at around USD 55.1 billion in 2023 and is estimated to grow at 12.8% CAGR from 2024 to 2032. The increasing burden of chronic and infectious diseases among the female population is driving growth in the market.
 

The rising prevalence of chronic conditions such as cancer, diabetes, hypertension, and mental health disorders, along with infectious diseases including HIV and tuberculosis, disproportionately affects women. This escalating burden underscores the urgent need for effective solutions to manage and mitigate these health issues. For instance, in 2022, the World Health Organization reported 2.3 million new breast cancer diagnoses and 670,000 deaths globally.
 

Femtech offers personalized and targeted tools to address these complex challenges, highlighting the need for innovative technology in tackling significant health concerns. Similarly, women are increasingly affected by conditions such as diabetes, hypertension, and cardiovascular diseases, which necessitate continuous management and monitoring. Limited access to healthcare resources, particularly in underserved regions, exacerbates these challenges.
 

Femtech, also referred to as female technology, encompasses a wide range of products, services, and software designed to address women's health concerns. This technology-driven industry focuses on various aspects of women’s health, including fertility solutions, pregnancy and nursing care, reproductive health, and overall wellness.
 

Femtech Market Trends

• In developed countries, digital technology is revolutionizing women’s health management through the expanding market, which offers a wide range of innovative tools, including mobile apps, wearable medical devices, telehealth services, and data-driven diagnostics. This transformation is driven by growing awareness of women’s unique health needs, encompassing areas such as reproductive health, fertility, menstrual care, and menopause. Social movements advocating for women’s health rights have also played a significant role in boosting demand for specialized femtech solutions.
   
• In developed nations, telemedicine has become integral to women’s healthcare, facilitating virtual consultations across various domains, including prenatal care, gynecology, mental health, and fertility treatments. For instance, data from the U.S. Department of Health and Human Services (HHS) reveals a staggering 63-fold increase in Medicare telehealth visits, rising from 840,000 in 2019 to 52.7 million in 2020. This rapid adoption highlights femtech's potential to broaden remote healthcare access and deliver personalized care tailored to women’s unique health requirements.
   
• Additionally, digital tools, such as smartwatches, wearables, and mobile apps, empower women to monitor their menstrual cycles, pregnancies, and overall health in real-time. For example, the Apple Watch’s cycle tracking feature and the Ava fertility tracker enable women to gather reproductive health data, enhancing personalized management and decision-making when shared with healthcare providers. Consequently, the femech market is poised for sustained growth, propelled by heightened awareness and advancements in digital healthcare solutions for women.
   

Femtech Market Analysis

Based on type, the market is segmented into product, software, and services. The software segment dominated the market in 2023 and accounted for USD 28.5 million.
 

• Increasing awareness of women's health, particularly in areas such as menstrual and reproductive health that were previously underrecognized, is driving growth in this sector. For instance, according to the World Health Organization (WHO), an estimated 1.9 billion women of reproductive age experience menstruation each month, underscoring the significant market potential.
   
• Additionally, digital health technologies, including mobile apps, AI, telehealth, and wearable devices, are enhancing access to personalized healthcare solutions for women. Tools such as AI-driven diagnostics, telemedicine, and menstrual and fertility tracking applications have led to a significant increase in prenatal care attendance, contributing to segmental growth.
   

Based on application, the femtech market is segmented into reproductive health, pregnancy care, maternal/postpartum and nursing care, integrative physical and mental health & overall well-being, and other applications. The reproductive health segment dominated the market in 2023 with a market share of 43.8%.
 

• Awareness of women’s specific health issues, such as fertility, menstruation, pregnancy, and menopause, has significantly increased due to social movements and educational campaigns, driving demand for specialized reproductive health solutions. This heightened awareness has created a more informed consumer base actively seeking reproductive health products and services.
   
• Furthermore, the reduction of social stigma surrounding menstruation, fertility, and menopause has facilitated more open discussions about these topics, resulting in increased consumer demand for related products and services.
   

 Based on end-use, the femtech market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and other end users. The direct-to-consumer segment is anticipated to reach USD 52.9 billion by 2032.
 

• Femtech companies are responding by providing customized solutions for menstrual health, menopause, and fertility through direct-to-consumer (DTC) channels. These companies utilize user data to refine and personalize their offerings, enhancing product efficacy and user satisfaction.
   
• Moreover, the DTC model provides a convenient shopping experience, allowing customers to access femtech products from home. This approach is particularly advantageous for products related to sensitive health issues or those requiring privacy, thereby contributing to the rising segment growth.
   

North America femtech market accounted for USD 17.8 billion market revenue in 2023 and is anticipated to grow at CAGR of 13% between 2024 to 2032 period.
 

• Growing awareness regarding women's health issues and the advantages of femtech solutions is fueling market demand. Women are increasingly seeking personalized, accessible, and efficient healthcare options. According to a 2021 survey by the Kaiser Family Foundation, 38% of women reported delaying or forgoing healthcare due to cost, highlighting the need for more accessible solutions in the region. These factors are collectively driving the growth of the North American market.
   

The U.S. held a dominant position in the femtech market, with a revenue of USD 15.9 billion in 2023.
 

• Technological advancements, including AI, machine learning, and advanced data analytics, are improving femtech products and services in the country, resulting in more effective and personalized health solutions.
   
• Furthermore, the transition to digital health solutions and telemedicine has improved healthcare accessibility. The Centers for Disease Control and Prevention (CDC) reported that telehealth visits in the U.S. increased by 154% during the last week of March 2020 compared to the same period in 2019, indicating a significant shift towards digital health solutions.
   

UK femtech market is anticipated to witness substantial growth during 2024 to 2032 timeframe.
 

• Investment in UK femtech startups is increasing, with venture capitalists and pharmaceutical companies providing significant funding. This capital influx is accelerating product development and market entry for innovative femtech solutions.
   
• Additionally, the UK’s robust technology ecosystem supports the development of advanced femtech solutions. Innovations in artificial intelligence, wearable devices, and mobile health applications are making sophisticated health management tools more accessible to users.
   

Japan holds a dominant position in the Asia Pacific femtech market.
 

• Governments in several Asia-Pacific countries are investing in healthcare innovation and supporting femtech solution development. These initiatives include research funding, health technology subsidies, and policies aimed at improving women's health.
   
• Additionally, cultural shifts towards gender equality and women's empowerment are influencing the market, with a growing recognition of the importance of addressing women's health issues and providing targeted solutions tailored to their needs.
   

Femtech Market Share

The market is inherently fragmented, comprising a mix of large multinational corporations and numerous small to mid-sized companies vying for market share. The key strategies driving growth in this sector include the development and introduction of innovative products, software, and services that offer enhanced accuracy, efficiency, and cost-effectiveness. As companies strive to remain competitive, their advancements in femtech are pivotal in capturing market share and meeting the increasing demand for sophisticated products and services.
 

Femtech Market Companies

Some of the eminent market participants operating in the femtech industry include:

• Amazon.com, Inc.
• AVA Women
• Clue (BioWink GmbH)
• Conceivable
• Daysy (Valley Electronics AG)
• Elvie (Chiaro Technology Ltd.)
• Flo Health Inc.
• Google Nest (Alphabet Inc.)
• HeraMED Limited
• LactApp Women's Health S.L.
• LunaJoy
• MASIMO CORPORATION
• Maven Clinic
• Nanit
• Natural Cycles
• Peppy Health Limited
• Preglife
• Pregnancy+ (Koninklijke Philips N.V.)
• Soula – AI (Mamatech Ltd.)
• Univfy Inc.
   

Femtech Industry News:

• In June 2024, HeraMED Limited announced the soft launch of HeraCARE in the Telstra Health Smart Connected Care ecosystem. HeraMED intends to expand its marketing and onboarding activities to a larger network by the end of 2024. As part of their Smart Partner Marketing Plan, the two firms will work together on educational and promotional initiatives. The initiative aims to expand the company's footprint in other locations.
   
• In January 2022, Univfy announced a strategic partnership with PracticeHwy's electronic medical records solution. The goal of the partnership is to bring a higher level of insight to fertility care by making these treatments more affordable, predictable, and successful. The partnership helped the company to gain a competitive edge over its peers.
   

Femtech market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type    

• Products
• Software
• Services

Market, By Application

• Reproductive health
  • Menstrual cycle & fertility
    • Contraception
    • Pregnancy testing
    • Fertility testing & conception support
    • Cycle monitoring
    • Reproductive health guidance
  • Menopause
• Pregnancy care
  • Pregnancy progress insights apps
  • Pregnancy exchange network & parental education
  • Pregnancy health guidance
  • Abortion & miscarriage support
• Maternal/postpartum and nursing care
  • Postpartum support
  • Breastfeeding & lactation support
  • Personal development
• Integrative physical and mental health & overall well-being
  • Pain relief and management
  • Pregnancy health monitoring
  • Parental health
  • Disease prevention and detection
• Other applications

Market, By End Use

• Direct-to-consumer
• Hospitals
• Fertility clinics
• Surgical centers
• Diagnostic centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa